GB0616666D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0616666D0
GB0616666D0 GB0616666A GB0616666A GB0616666D0 GB 0616666 D0 GB0616666 D0 GB 0616666D0 GB 0616666 A GB0616666 A GB 0616666A GB 0616666 A GB0616666 A GB 0616666A GB 0616666 D0 GB0616666 D0 GB 0616666D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0616666A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB0616666A priority Critical patent/GB0616666D0/en
Publication of GB0616666D0 publication Critical patent/GB0616666D0/en
Priority to KR1020087009313A priority patent/KR20080049113A/en
Priority to CN2006800374681A priority patent/CN101287760B/en
Priority to EP12172979A priority patent/EP2532677A1/en
Priority to ARP060104563A priority patent/AR058104A1/en
Priority to RU2008119689/10A priority patent/RU2421464C2/en
Priority to EP12173018.8A priority patent/EP2532679B1/en
Priority to MYPI20081170A priority patent/MY144906A/en
Priority to CA2625664A priority patent/CA2625664C/en
Priority to PT121730188T priority patent/PT2532679T/en
Priority to EP06806402A priority patent/EP1957530A2/en
Priority to AU2006303452A priority patent/AU2006303452B2/en
Priority to BRPI0617485A priority patent/BRPI0617485B8/en
Priority to JP2008535972A priority patent/JP5006330B2/en
Priority to NZ567124A priority patent/NZ567124A/en
Priority to KR1020137002695A priority patent/KR20130020850A/en
Priority to PL12173018T priority patent/PL2532679T3/en
Priority to PCT/EP2006/010098 priority patent/WO2007045477A2/en
Priority to EP12173002A priority patent/EP2532678A1/en
Priority to KR1020107028697A priority patent/KR101461263B1/en
Priority to PE2006001269A priority patent/PE20080036A1/en
Priority to US12/091,020 priority patent/US7910708B2/en
Priority to TW095138861A priority patent/TWI431013B/en
Priority to IL190332A priority patent/IL190332A/en
Priority to CR9867A priority patent/CR9867A/en
Priority to MA30847A priority patent/MA29869B1/en
Priority to EC2008008388A priority patent/ECSP088388A/en
Priority to NO20082309A priority patent/NO20082309L/en
Priority to US12/975,667 priority patent/US8580260B2/en
Priority to JP2012050499A priority patent/JP5684174B2/en
Priority to US14/044,314 priority patent/US8992916B2/en
Priority to US14/629,587 priority patent/US9650438B2/en
Ceased legal-status Critical Current

Links

GB0616666A 2005-10-21 2006-08-22 Organic compounds Ceased GB0616666D0 (en)

Priority Applications (32)

Application Number Priority Date Filing Date Title
GB0616666A GB0616666D0 (en) 2006-08-22 2006-08-22 Organic compounds
PL12173018T PL2532679T3 (en) 2005-10-21 2006-10-19 Human antibodies against il13 and therapeutic uses
NZ567124A NZ567124A (en) 2005-10-21 2006-10-19 Human antibodies against Interleukin-13 and therapeutic uses to treat asthma
US12/091,020 US7910708B2 (en) 2005-10-21 2006-10-19 Anti-IL13 human antibodies
EP12172979A EP2532677A1 (en) 2005-10-21 2006-10-19 Human antibodies against il13 and therapeutic uses
ARP060104563A AR058104A1 (en) 2005-10-21 2006-10-19 ORGANIC COMPOUNDS
RU2008119689/10A RU2421464C2 (en) 2005-10-21 2006-10-19 Human il-13 antibodies and their therapeutic application
EP12173018.8A EP2532679B1 (en) 2005-10-21 2006-10-19 Human antibodies against il13 and therapeutic uses
PCT/EP2006/010098 WO2007045477A2 (en) 2005-10-21 2006-10-19 Human antibodies against il-13 and therapeutic uses
CA2625664A CA2625664C (en) 2005-10-21 2006-10-19 Human antibodies against il13 and therapeutic uses
PT121730188T PT2532679T (en) 2005-10-21 2006-10-19 Human antibodies against il13 and therapeutic uses
EP06806402A EP1957530A2 (en) 2005-10-21 2006-10-19 Human antibodies against il13 and therapeutic uses
AU2006303452A AU2006303452B2 (en) 2005-10-21 2006-10-19 Human antibodies against IL13 and therapeutic uses
CN2006800374681A CN101287760B (en) 2005-10-21 2006-10-19 Anti-IL13 human antibodies
JP2008535972A JP5006330B2 (en) 2005-10-21 2006-10-19 Human antibodies against IL13 and therapeutic uses
KR1020087009313A KR20080049113A (en) 2005-10-21 2006-10-19 Human antibodies against il-13 and therapeutic uses
KR1020137002695A KR20130020850A (en) 2005-10-21 2006-10-19 Human antibodies against il-13 and therapeutic uses
BRPI0617485A BRPI0617485B8 (en) 2005-10-21 2006-10-19 isolated anti-human IL-13 antibody, pharmaceutical composition and use of said antibody
MYPI20081170A MY144906A (en) 2005-10-21 2006-10-19 Human antibodies against il13 and therapeutic uses
EP12173002A EP2532678A1 (en) 2005-10-21 2006-10-19 Human antibodies against il13 and therapeutic uses
KR1020107028697A KR101461263B1 (en) 2005-10-21 2006-10-19 Human antibodies against IL-13 and therapeutic uses
PE2006001269A PE20080036A1 (en) 2005-10-21 2006-10-19 HUMAN ANTIBODIES TO INTERLEUKIN-13 (IL13)
TW095138861A TWI431013B (en) 2005-10-21 2006-10-20 Organic molecules
IL190332A IL190332A (en) 2005-10-21 2008-03-20 Isolated human or humanized il 13 antibody comprising an antigen-binding region and pharmaceutical composition comprising it
CR9867A CR9867A (en) 2005-10-21 2008-04-04 HUMAN ANTIBODIES AGAINST IL13 AND THERAPEUTIC USES
MA30847A MA29869B1 (en) 2005-10-21 2008-04-15 ORGANIC MOLECULES
EC2008008388A ECSP088388A (en) 2005-10-21 2008-04-18 HUMAN ANTIBODIES AGAINST IL13 AND THERAPEUTIC USES
NO20082309A NO20082309L (en) 2005-10-21 2008-05-21 Organic molecules
US12/975,667 US8580260B2 (en) 2005-10-21 2010-12-22 Method of using anti-IL-13 antibodies
JP2012050499A JP5684174B2 (en) 2005-10-21 2012-03-07 Human antibodies against IL13 and therapeutic uses
US14/044,314 US8992916B2 (en) 2005-10-21 2013-10-02 Methods of using anti-IL13 human antibodies
US14/629,587 US9650438B2 (en) 2005-10-21 2015-02-24 Nucleic acid encoding anti-IL13 human antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0616666A GB0616666D0 (en) 2006-08-22 2006-08-22 Organic compounds

Publications (1)

Publication Number Publication Date
GB0616666D0 true GB0616666D0 (en) 2006-10-04

Family

ID=37102678

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0616666A Ceased GB0616666D0 (en) 2005-10-21 2006-08-22 Organic compounds

Country Status (1)

Country Link
GB (1) GB0616666D0 (en)

Similar Documents

Publication Publication Date Title
GB0606774D0 (en) Organic compounds
EP2023729A4 (en) Organic compounds
GB0603684D0 (en) Organic compounds
EP2081431A4 (en) Organic compounds
GB0605691D0 (en) Organic Compounds
GB0606429D0 (en) Organic compounds
GB0611695D0 (en) Organic compounds
GB0605120D0 (en) Organic Compounds
GB0605688D0 (en) Organic compounds
GB0605689D0 (en) Organic compounds
GB0604937D0 (en) Organic compounds
GB0601406D0 (en) Organic Compounds
GB0601031D0 (en) Organic compounds
GB0602123D0 (en) Organic compounds
GB0601951D0 (en) Organic compounds
GB0606804D0 (en) Organic Compounds
GB0603782D0 (en) Organic compounds
ZA200805331B (en) Organic compounds
GB0606562D0 (en) Organic compounds
GB0603880D0 (en) Organic compounds
GB0606202D0 (en) Organic compounds
GB0601405D0 (en) Organic Compounds
GB0600618D0 (en) Organic compounds
GB0600238D0 (en) Organic compounds
GB0603568D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)